These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31235749)

  • 1. Small Molecule IL-36γ Antagonist as a Novel Therapeutic Approach for Plaque Psoriasis.
    Todorović V; Su Z; Putman CB; Kakavas SJ; Salte KM; McDonald HA; Wetter JB; Paulsboe SE; Sun Q; Gerstein CE; Medina L; Sielaff B; Sadhukhan R; Stockmann H; Richardson PL; Qiu W; Argiriadi MA; Henry RF; Herold JM; Shotwell JB; McGaraughty SP; Honore P; Gopalakrishnan SM; Sun CC; Scott VE
    Sci Rep; 2019 Jun; 9(1):9089. PubMed ID: 31235749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment.
    Mercurio L; Morelli M; Scarponi C; Eisenmesser EZ; Doti N; Pagnanelli G; Gubinelli E; Mazzanti C; Cavani A; Ruvo M; Dinarello CA; Albanesi C; Madonna S
    Cell Death Dis; 2018 Oct; 9(11):1104. PubMed ID: 30377293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin (IL)-17/IL-36 axis participates to the crosstalk between endothelial cells and keratinocytes during inflammatory skin responses.
    Mercurio L; Failla CM; Capriotti L; Scarponi C; Facchiano F; Morelli M; Rossi S; Pagnanelli G; Albanesi C; Cavani A; Madonna S
    PLoS One; 2020; 15(4):e0222969. PubMed ID: 32352958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
    Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
    Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-36α and IL-36γ expressions in the differential diagnosis of palmoplantar psoriasis and palmoplantar eczema: A retrospective histopathologic and immunohistochemical study.
    Erdem O; Leblebici C; Koku Aksu AE; Erdil D; Kara Polat A; Gürel MS
    J Cutan Pathol; 2022 Jan; 49(1):42-48. PubMed ID: 34289144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-36γ inhibits differentiation and induces inflammation of keratinocyte via Wnt signaling pathway in psoriasis.
    Wang W; Yu X; Wu C; Jin H
    Int J Med Sci; 2017; 14(10):1002-1007. PubMed ID: 28924372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Boutet MA; Bart G; Penhoat M; Amiaud J; Brulin B; Charrier C; Morel F; Lecron JC; Rolli-Derkinderen M; Bourreille A; Vigne S; Gabay C; Palmer G; Le Goff B; Blanchard F
    Clin Exp Immunol; 2016 May; 184(2):159-73. PubMed ID: 26701127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions.
    D'Erme AM; Wilsmann-Theis D; Wagenpfeil J; Hölzel M; Ferring-Schmitt S; Sternberg S; Wittmann M; Peters B; Bosio A; Bieber T; Wenzel J
    J Invest Dermatol; 2015 Apr; 135(4):1025-1032. PubMed ID: 25525775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small-molecule elastase inhibitors as antagonists of IL-36 cytokine activation.
    Sullivan GP; Davidovich PB; Sura-Trueba S; Belotcerkovskaya E; Henry CM; Clancy DM; Zinoveva A; Mametnabiev T; Garabadzhiu AV; Martin SJ
    FEBS Open Bio; 2018 May; 8(5):751-763. PubMed ID: 29744290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis.
    Madonna S; Girolomoni G; Dinarello CA; Albanesi C
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal IL-36γ/IL-36R participates in the maintenance of chronic inflammatory pain through astroglial JNK pathway.
    Li Q; Liu S; Li L; Ji X; Wang M; Zhou J
    Glia; 2019 Mar; 67(3):438-451. PubMed ID: 30578562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-36γ Is a Strong Inducer of IL-23 in Psoriatic Cells and Activates Angiogenesis.
    Bridgewood C; Fearnley GW; Berekmeri A; Laws P; Macleod T; Ponnambalam S; Stacey M; Graham A; Wittmann M
    Front Immunol; 2018; 9():200. PubMed ID: 29535706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity.
    Towne JE; Renshaw BR; Douangpanya J; Lipsky BP; Shen M; Gabel CA; Sims JE
    J Biol Chem; 2011 Dec; 286(49):42594-42602. PubMed ID: 21965679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-36α from Skin-Resident Cells Plays an Important Role in the Pathogenesis of Imiquimod-Induced Psoriasiform Dermatitis by Forming a Local Autoamplification Loop.
    Hashiguchi Y; Yabe R; Chung SH; Murayama MA; Yoshida K; Matsuo K; Kubo S; Saijo S; Nakamura Y; Matsue H; Iwakura Y
    J Immunol; 2018 Jul; 201(1):167-182. PubMed ID: 29794016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of IL-36 cytokines in folliculitis and eosinophilic pustular folliculitis.
    Sato S; Chiba T; Nakahara T; Furue M
    Australas J Dermatol; 2020 Feb; 61(1):e39-e45. PubMed ID: 31424098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions.
    Sachen KL; Arnold Greving CN; Towne JE
    Cytokine; 2022 Aug; 156():155897. PubMed ID: 35679693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ.
    Ainscough JS; Macleod T; McGonagle D; Brakefield R; Baron JM; Alase A; Wittmann M; Stacey M
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2748-E2757. PubMed ID: 28289191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-17A synergistically enhances TLR3-mediated IL-36γ production by keratinocytes: A potential role in injury-amplified psoriatic inflammation.
    Liu S; Wu F; Wu Z; Li Y; Zhang S; Yu N
    Exp Dermatol; 2019 Mar; 28(3):233-239. PubMed ID: 30614571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin (IL)-8 and IL-36γ but not IL-36Ra are related to acrosyringia in pustule formation associated with palmoplantar pustulosis.
    Xiaoling Y; Chao W; Wenming W; Feng L; Hongzhong J
    Clin Exp Dermatol; 2019 Jan; 44(1):52-57. PubMed ID: 29896852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Topical Treatment for Psoriasis Targeting RORγ: From Bench to Skin.
    Smith SH; Peredo CE; Takeda Y; Bui T; Neil J; Rickard D; Millerman E; Therrien JP; Nicodeme E; Brusq JM; Birault V; Viviani F; Hofland H; Jetten AM; Cote-Sierra J
    PLoS One; 2016; 11(2):e0147979. PubMed ID: 26870941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.